Naloxone HCL 10 vials

$250.00

    • Naloxone Hydrochloride Injection, USP is a sterile, nonpyrogenic solution of naloxone hydrochloride in water for injection. Each milliliter (mL) contains 0.4 mg naloxone hydrochloride and sodium …
    • CLINICAL PHARMACOLOGY
      Complete or Partial Reversal of Opioid Depression – Naloxone prevents or reverses the effects of opioids including respiratory depression, sedation and hypotension. Also, Naloxone can reverse the …
    • PHARMACOKINETICS
      Distribution – Following parenteral administration naloxone is rapidly distributed in the body and readily crosses the placenta. Plasma protein binding occurs but is relatively weak. Plasma …
    • INDICATIONS AND USAGE
      Naloxone Hydrochloride Injection is indicated for the complete or partial reversal of opioid depression, including respiratory depression, induced by natural and synthetic opioids including …
    • CONTRAINDICATIONS
      Naloxone hydrochloride injection is contraindicated in patients known to be hypersensitive to naloxone hydrochloride or to any of the other ingredients contained in the formulation.
    • WARNINGS
      Drug Dependence – Naloxone hydrochloride injection should be administered cautiously to persons, including newborns of mothers, who are known or suspected to be physically dependent on opioids. In …
    • PRECAUTIONS
      General – In addition to naloxone, other resuscitative measures such as maintenance of a free airway, artificial ventilation, cardiac massage, and vasopressor agents should be available and …
    • ADVERSE REACTIONS
      Postoperative – The following adverse events have been associated with the use of naloxone hydrochloride injection in postoperative patients: hypotension, hypertension, ventricular tachycardia and …
    • DRUG ABUSE AND DEPENDENCE
      Naloxone hydrochloride injection is an opioid antagonist. Physical dependence associated with the use of naloxone hydrochloride injection has not been reported. Tolerance to the opioid antagonist …
    • OVERDOSAGE
      There is limited clinical experience with naloxone hydrochloride injection overdosage in humans. Adult Patients – In one small study, volunteers who received 24 mg/70 kg did not demonstrate …
    • DOSAGE AND ADMINISTRATION
      Naloxone Hydrochloride Injection, USP may be administered intravenously, intramuscularly, or subcutaneously. The most rapid onset of action is achieved by intravenous administration and it is …
    • HOW SUPPLIED
      Naloxone Hydrochloride Injection, USP is supplied in the following: Unit of SaleConcentration – NDC 0409-1215-01 – Carton of 10 – Single-dose Fliptop Vials – 0.4 mg/1 mL (0.4 …
    • PRINCIPAL DISPLAY PANEL – 1 mL Vial Label
      NDC 0409-1215-21 – 1 mL Single-dose – NALOXONE HCl – Injection, USP 0.4 mg/mL – For I.V., I.M., or S.C. use. Protect from light. Rx only – Hospira – Distributed by – Hospira, Inc., Lake Forest, IL 60045 …
    • PRINCIPAL DISPLAY PANEL – 1 mL Vial Carton
      1 mL Single-dose Fliptop Vial – NDC 0409-1215-01 – Contains 10 of NDC 0409-1215-21 – NALOXONE HYDROCHLORIDE – Injection, USP – Rx only – 0.4 mg/mL – Protect from light. For Intravenous, Intramuscular, or …
    • PRINCIPAL DISPLAY PANEL – 10 mL Vial Label
      10 mL Multiple-dose – NALOXONE HCl – Injection, USP – 4 mg/10 mL (0.4 mg/mL) Protect from light. For I.V., I.M. or S.C. use. Dist. by Hospira, Inc., Lake Forest, IL 60045 USA
    • PRINCIPAL DISPLAY PANEL – 10 mL Vial Carton
      One Unit/NDC 0409-1219-41 – 10 mL Multiple-dose Fliptop Vial – NALOXONE – HYDROCHLORIDE – Injection, USP – 4 mg/10 mL – (0.4 mg/mL) Protect from light. Rx only – Hospira
  • INGREDIENTS AND APPEARANCE
    Product Information